Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. 2005

David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
World Health Organization, Via Appia 20, CH-1211 Geneva, Switzerland.

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013995 Time The dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Effects, Long-Term,Effects, Longterm,Long-Term Effects,Longterm Effects,Effect, Long-Term,Effect, Longterm,Effects, Long Term,Long Term Effects,Long-Term Effect,Longterm Effect
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B
D017589 Immunization Programs Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. Vaccination Awareness,Vaccination Campaign,Vaccination Promotion,Awareness, Vaccination,Awarenesses, Vaccination,Campaign, Vaccination,Campaigns, Vaccination,Immunization Program,Program, Immunization,Programs, Immunization,Promotion, Vaccination,Promotions, Vaccination,Vaccination Awarenesses,Vaccination Campaigns,Vaccination Promotions

Related Publications

David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
January 2019, Medical journal of the Islamic Republic of Iran,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
January 2001, European journal of epidemiology,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
June 1988, Asian Pacific journal of allergy and immunology,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
January 2005, Lancet (London, England),
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
August 2000, Lancet (London, England),
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
May 2009, Hepatology (Baltimore, Md.),
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
December 1992, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
January 1992, American journal of nephrology,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
July 1986, The New England journal of medicine,
David Fitzsimons, and Guido François, and Andrew Hall, and Brian McMahon, and André Meheus, and Alessandro Zanetti, and Bernard Duval, and Wolfgang Jilg, and Wulf Otto Böcher, and Sheng-Nan Lu, and Ulus Akarca, and Daniel Lavanchy, and Susan Goldstein, and Jangu Banatvala, and Pierre Van Damme
March 2009, International journal of clinical practice,
Copied contents to your clipboard!